Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: screening natural products, small molecules and antibodies

Haochun Jin,Dianxin Cui,Yu Fan,Guodong Li,Zhangfeng Zhong,Yitao Wang
DOI: https://doi.org/10.1016/j.drudis.2024.103885
IF: 8.369
2024-01-28
Drug Discovery Today
Abstract:Bioaffinity drug screening strategies have gained popularity in preclinical and clinical drug discovery for natural products, small molecules and antibodies owing to their superior selectivity, the large number of compounds to be screened and their ability to reduce the time and cost of the drug discovery process. This paper provides a systematic summary of the principles of commonly used bioaffinity-based screening methods, elaborates on the success of bioaffinity in clinical drug development...
pharmacology & pharmacy
What problem does this paper attempt to address?